<DOC>
	<DOCNO>NCT02839044</DOCNO>
	<brief_summary>Arterial calcification independent predictor coronary event associate 3-4 fold increase risk cardiovascular event . Currently , effective intervention exist reduce arterial calcification . However , recent study show vitamin K may reduce ongoing calcium deposition artery , thereby inhibit arterial calcification . The primary objective determine MK-7 supplementation lead stabilization attenuation ongoing calcium deposition femoral artery quantify 18F-NaF PET/CT imaging patient type 2 diabetes arterial disease .</brief_summary>
	<brief_title>A Randomized , Placebo-controlled , Double Blind Trial Investigate Whether Vitamin K2 Can Influence Arterial Calcification Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Vitamin MK 7</mesh_term>
	<criteria>Middle age men woman , ≥ 40 year . Diagnosed type 2 diabetes . Presence arterial disease , base Ankle Brachial Index ( ABI ) &lt; 0.9 and/or diagnose arterial disease physician . ABI &lt; 0.9 Written informed consent . Subjects participate another intervention research study use image . Contraindication undergoing18FNaF PET/CT scan ( claustrophobia , pregnancy , breastfeed ) . Subject underwent amputation low extremity ( knee ) . Using vitamin K antagonist . Known coagulation problem ( history Venous Thrombo Embolism ) . Using vitamin supplement contain vitamin K , vitamin D calcium , unwilling stop two week randomisation . A mean vitamin K2 intake ≥120 microgram/day measure questionnaire . Natto goose liver consumer . Low kidney function ( eGFR &lt; 30 ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>